New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 6, 2014
08:36 EDTNUVANuVasive announces favorable resolution of patent lawsuit against Cadwell Labs
NuVasive announced that it reached a settlement agreement with Cadwell Laboratories in a lawsuit involving NuVasive's patented neuromonitoring technology. NuVasive filed the lawsuit in December 2012 asserting that Cadwell infringed on the company's patented neuromonitoring technology, including the integration of nerve monitoring technology during lateral approach spine surgery. As part of the settlement reached between the parties, Cadwell has agreed to exit the lateral spine surgery market, and to no longer provide products, services, or support for lateral approach spine fusion surgeries. In addition, certain of Cadwell's future products may be required to openly attribute intellectual property ownership to NuVasive and may require a 5% fee paid to NuVasive.
News For NUVA From The Last 14 Days
Check below for free stories on NUVA the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 29, 2014
18:35 EDTNUVAOn The Fly: After Hours Movers
Subscribe for More Information
16:42 EDTNUVANuVasive raises FY14 EPS view to $1.11 from $1.06, consensus $1.09
Subscribe for More Information
16:40 EDTNUVANuVasive reports Q2 EPS 28c, consensus 25c
Reports Q2 revenue $190.7M, consensus $177.45M.
July 24, 2014
08:19 EDTNUVALeerink medical devices analyst holds an analyst/industry conference call
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use